Haemonetics published a landmark multicenter study comparing the TEG 6s and TEG 5000 systems in trauma patients reaching an important scientific milestone with ~100 citations.
Published
Signal category
Research & Knowledge
Quote
“A landmark multicenter study comparing the TEG® 6s and TEG® 5000 systems in trauma patients has now reached an important scientific milestone: ~ 100 citations.”
— Haemonetics team
Company
Haemonetics
We make it possible. You make it matter.
- Industry
- Medical Equipment Manufacturing
- Location
- Boston, US
- Company size
- 2,540 employees
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our Apheresis business features proprietary technologies designed to enhance safety, yield, donor satisfaction and operational efficiency for plasma and blood collectors around the world. Our MedSurg business offers Blood Management Technologies to help inform treatment decisions and optimize the management of blood products, and Interventional Technologies, including advanced vascular closure systems and sensor-guided technologies, designed to drive procedural effectiveness and elevate the patient experience. To learn more about Haemonetics, visit www.haemonetics.com.
Founded 1971